LAG3 IHC Melanoma
Use
The LAG3 assay is intended for use in the detection of LAG3 in formalin-fixed, paraffin-embedded (FFPE) tissue sections in melanoma.
Special Instructions
Not provided.
Limitations
The use of fixatives other than 10% formalin may not yield equivalent or satisfactory results. This test has not been cleared or approved by the FDA, and it was developed by Labcorp with its performance characteristics determined internally.
Methodology
Immunoassay (IHC)
Biomarkers
LAG3
Protein
LOINC Codes
- 55229-9 - Immune stain study
- 77202-0 - Laboratory comment Report
- 50595-8 - Path Interp Spec-Imp
- 19139-5 - Pathologist name
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Paraffin block or 5 unstained slides
Minimum Volume
Paraffin block or 5 unstained slides
Container
Paraffin block or slide
Collection Instructions
Tissue should be fixed in 10% neutral buffered formalin for no more than 72 hours. Embed in paraffin.
Storage Instructions
Room temperature
Causes for Rejection
Insufficient tissue; tumor other than melanoma
Other tests from different labs that may be relevant